How does sapropterin dosing vary by patient?

Standard Dosing for Sapropterin (Kuvan)

Sapropterin dihydrochloride, used to manage blood phenylalanine levels in phenylketonuria (PKU) patients responsive to the drug, starts at 10 mg/kg body weight once daily via oral tablet or powder dissolved in water[1]. Providers adjust based on weekly blood phenylalanine monitoring, typically increasing by 5 mg/kg every 1-2 weeks up to a maximum of 20 mg/kg/day if levels remain elevated[1][2].

Dosing Adjustments by Age

• Children under 4 years: Same 10 mg/kg starting dose, but efficacy data is limited; use only if benefits outweigh risks, with close monitoring[1].
  
• Children 4 years and older, adolescents, adults: Full adult dosing applies (10-20 mg/kg/day), with responsiveness more reliably assessed in this group[2].
  
  No specific geriatric adjustments, but elderly patients may need renal function checks due to potential age-related declines[1].
  
  

Dosing by Weight Changes and Response

Dosing relies on actual body weight, recalculated frequently in growing children. Non-responders (phenylalanine drop <30% after 4 weeks at 20 mg/kg) discontinue therapy. Partial responders may stabilize at intermediate doses like 15 mg/kg[1][2]. Tablets can be cut for precise weight-based amounts; powder allows finer adjustments.

| Patient Weight (kg) | Starting Dose Example (10 mg/kg) | Max Dose Example (20 mg/kg) |
|---------------------|----------------------------------|-----------------------------|
| 10 | 100 mg (1 tablet) | 200 mg (2 tablets) |
| 20 | 200 mg (2 tablets) | 400 mg (4 tablets) |
| 40 | 400 mg (4 tablets) | 800 mg (8 tablets) |
| 70+ | 700+ mg (7+ tablets or powder) | 1400 mg (powder preferred) |

Dosing in Renal or Hepatic Impairment

Mild renal/hepatic impairment: No change needed. Moderate to severe: Start at lower end (5-10 mg/kg) and titrate cautiously, as drug exposure increases up to 1.5-fold[1]. Dialysis patients lack specific data; monitor closely.

Special Populations and Coadministration

• Pregnant patients: Limited data; use lowest effective dose to control phenylalanine, as high maternal levels risk fetal harm[2].
  
• Drug interactions: Avoid with PDE-5 inhibitors (e.g., sildenafil) due to hypotension risk—reduce sapropterin to 5 mg/kg if coadministered[1].
  Patients often take it with medical foods and low-phenylalanine diets for optimal control[2].
  
  [1]: Kuvan (sapropterin) Prescribing Information
  [2]: Drugs.com - Sapropterin Dosage Guide